NCT01924026View on ClinicalTrials.gov

Neurocognitive Outcomes in Mild Hyperphenylalaninemia (MHP)MHP Study

CompletedOBSERVATIONAL

Enrollment

10

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

February 29, 2016

Study Completion Date

February 29, 2016

Conditions

PhenylketonuriaMild Hyperphenylalaninemia

Trial Locations (1)

M5G 1X8

The Hospital for Sick Children, Toronto

Sponsors

Collaborators (1)

BioMarin Pharmaceutical

All Listed Sponsors

collaborator

BioMarin Pharmaceutical

INDUSTRY

lead

The Hospital for Sick Children

OTHER